U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07516314) titled 'ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant Patients' on March 19.
Brief Summary: This study is a phase 2, multicenter, randomized controlled trial to test the application of Acceptance and Commitment Therapy (ACT) in HCT patients.
ACT is an evidence-based cognitive behavioral therapy intervention that emphasizes psychological flexibility and behaviors, helping transplant patients focus on actions that may help maintain adequate physical activity despite physical and emotional discomfort.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Stem Cell Transplant Patients
Intervention...